Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome

Am J Hematol. 2015 Aug;90(8):E152-3. doi: 10.1002/ajh.24059. Epub 2015 May 29.

Authors

Affiliations

¹ Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
² Fondazione IRCCS C. Mondino, Institute of Neurology, Pavia, Italy.
³ Department of Molecular Medicine, University of Pavia, Pavia, Italy.
⁴ Division of Neurology, Ospedale Civile Di Voghera, Italy.
⁵ Radiology and Neuroradiology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

PMID: 25975811
DOI: 10.1002/ajh.24059

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Antineoplastic Agents / therapeutic use*
Bendamustine Hydrochloride
Bone Marrow / drug effects
Bone Marrow / metabolism
Bone Marrow / pathology
Central Nervous System Neoplasms / complications
Central Nervous System Neoplasms / drug therapy*
Central Nervous System Neoplasms / metabolism
Central Nervous System Neoplasms / pathology
Humans
Immunologic Factors / therapeutic use*
Male
Middle Aged
Nitrogen Mustard Compounds / therapeutic use*
Remission Induction
Rituximab
Treatment Outcome
Waldenstrom Macroglobulinemia / complications
Waldenstrom Macroglobulinemia / drug therapy*
Waldenstrom Macroglobulinemia / metabolism
Waldenstrom Macroglobulinemia / pathology

Substances

Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Immunologic Factors
Nitrogen Mustard Compounds
Rituximab
Bendamustine Hydrochloride